Followers | 16 |
Posts | 2067 |
Boards Moderated | 0 |
Alias Born | 02/28/2011 |
Monday, April 21, 2014 9:17:34 PM
http://www.exobox-shareholder.com/xdocs/articles/EXBX%20By%20Laws.pdf
(see page 13, ARTICLE IX Approval of Certain Business Combintations)
I thought the proposed share exchange agreement 8-K filing stated: "The current control person is Shaun Irvine, who holds all of the outstanding Series D Convertible Preferred Stock, giving him the right to convert into, and in the interim exercise the voting power, of 500 million shares of common stock. This is equivalent to approximately 51% of the Company's outstanding shares on a fully diluted basis."
http://www.sec.gov/Archives/edgar/data/1335002/000100233414000006/f8kacquisition.htm
So wow am I curious to see how the consideration of approximately $50,000 in cash in which the Company issued 5,000 shares of Series D Convertible Preferred Stock to its sole officer and director Shaun Irvine, does that consideration of approximately $50,000 in cash give Shaun Irvine the right to convert into, and in the interim exercise the voting power, of 500 million shares of common stock.
And I wonder if there was another 24% of the Company's outstanding shares that would make the company believe they could effect a 1-for-2000 reverse split without a shareholder vote.
I saw nothing in regards to the company asking shareholders for their approval on the proposed share exchange agreement.
I saw nothing in regards to the company asking shareholders for their approval on the appointment of the Board of Directors.
I saw nothing in regards to the company holding an annual shareholder meeting.
I saw nothing in regards to the company holding a new shareholder vote for the election of a new EXBX Board of Directors.
Stay tuned!
Hoping for more details on that last proposed share exchange agreement.
Hoping for some more info on the last shareholder vote.
Hoping for more details on all the share count changes and issued shares of stock for the last number of years.
Go EXBX !!!!
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM